Susceptibility profile and β-lactamase content of global Pseudomonas aeruginosa isolates resistant to ceftolozane/tazobactam and/or imipenem/relebactam—SMART 2016–21
Author:
Affiliation:
1. IHMA, Inc. , Schaumburg, IL , USA
2. Department of Medical Microbiology and Infectious Diseases, Max Rady College of Medicine, University of Manitoba , Winnipeg, Manitoba , Canada
3. Merck & Co., Inc. , Rahway, NJ , USA
Abstract
Funder
Merck Sharp & Dohme LLC
Publisher
Oxford University Press (OUP)
Subject
Microbiology (medical),Infectious Diseases,Immunology and Allergy,Microbiology,Immunology
Link
https://academic.oup.com/jacamr/article-pdf/5/3/dlad080/50731534/dlad080.pdf
Reference47 articles.
1. The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update;Reynolds;Drugs,2021
2. In vitro activity of imipenem/relebactam and ceftolozane/tazobactam against clinical isolates of gram-negative bacilli with difficult-to-treat resistant phenotypes—study for monitoring antimicrobial resistance trends, United States 2015–2017;Karlowsky;Clin Infect Dis,2021
3. In vitro activity of ceftolozane-tazobactam, imipenem-relebactam, ceftazidime-avibactam, and comparators against Pseudomonas aeruginosa isolates collected in United States hospitals according to results from the SMART surveillance program, 2018 to 2020;Karlowsky;Antimicrob Agents Chemother,2022
4. Infectious Diseases Society of America guidance on the treatment of extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa);Tamma;Clin Infect Dis,2021
5. New perspectives on antimicrobial agents: ceftolozane-tazobactam;Lizza;Antimicrob Agents Chemother,2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3